Considerations in Hematopoietic Cell Transplantation (HCT) for Severe Autoimmune Diseases; Co-sponsored by the European Group for Blood and Marrow Transplantation (EBMT), the Center for International Blood and Marrow Transplant Research (CIBMTR), and NIAI

The goals of this conference are to (1) facilitate international discussion and team-building of hematopoietic cell transplant physicians and autoimmune disease experts to work together for treatment of patients with autoimmune diseases, (2) focus on the aspects of HCT therapy that are particularly challenging for autoimmune diseases, (3) identify questions for future clinical research, and (4) consider the potential for international collaboration in clinical studies.